Clinical Research
Key Take-Away:

Thiazide diuretic may decrease the risk of fracture, indicating the protective effect of this class in clinical practice.

Osteoporosis is a major chronic condition worldwide, and the major health issue in the USA especially in the aging population. About 300,000 people aged 65 and older are hospitalized each year due to hip fracture, a situation which often leads to decreased quality of life.

Osteoporosis Int. 2018 Mar 25
20min read    
Clinical Research
Key Take-Away:

In middle-aged people with mild radiographic osteoarthritis (OA), structural features changes do occur  a little over a year, irrespective of weight patients loss status.

Osteoarthritis (OA) is a principal cause of disability and a more massive public health problem in the United States.

Osteoarthritis and Cartilage
20min read    
Clinical Research
Key Take-Away:

Home-based, telephone-delivered Cognitive-Behavioral Therapy (CBT) and Supportive Care (SC) treatments did not significantly differ in their benefits for back pain severity and disability, and may warrant further research for applications to hospital settings.

Over the past decade, there is a drastically hype in the prevalence of chronic back pain (CBP) in the US population, advising a need for more treatment resources.

The Clinical Journal of Pain 2018;34(4): 322–327
22min read    
Systematic Reviews
Key Take-Away:

Intra-articular administration of dexmedetomidine (DEX) improved pain outcomes in the early postoperative period after knee arthroscopy

Arthroscopic knee surgery is a surgical procedure that can diagnose and treat problems in the knee joint. Patients with knee pain are managed on a day-case basis; therefore, appropriate postoperative pain relief is critical to facilitate patient discharge and early recovery.

Sci Rep. 2018 Mar 6;8(1):4089.
17min read    
Abstracts
Key Take-Away:

The problem of a migraine is considered among the ten most disabling disorders that may arise in any age group. Various medications are available for the prevention and treatment of a migraine in pediatric patients. This study enlightens the efficacy of an approved anticonvulsant drug topiramate among adolescents generating mixed results.

Based on the success of treatment, various medications are prescribed to prevent pediatric migraines. Topiramate, the drug approved for migraine prevention in children as young as 12 years of age. 

8min read